| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.2B | $0.2B | $0.2B | $0.1B | $0.1B | $0.2B | $0.2B | $0.1B |
| EPS (Basic) | $3.72 | $3.65 | $2.71 | $1.17 | $2.35 | $2.52 | $2.33 | $2.22 |
| EPS (Diluted) | $3.70 | $3.63 | $2.70 | $1.17 | $2.34 | $2.51 | $2.32 | $2.21 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $18.9B | $18.2B | $18.7B | $18.0B | $17.6B | $16.6B | $13.5B | $13.3B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — | — | $0.3B |
| Total Liabilities | $16.8B | $16.2B | $17.1B | $16.5B | $15.9B | $14.8B | $11.8B | $11.7B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $2.1B | $2.0B | $1.7B | $1.5B | $1.7B | $1.7B | $1.7B | $1.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.2B | $0.1B | $0.2B | $0.3B | $0.3B | $0.1B | $0.1B | $0.2B |
| Investing Cash Flow | $-0.6B | $0.3B | $-0.4B | $-2.3B | $-1.0B | $-1.2B | $-0.1B | $0.4B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $0.4B | $-0.8B | $0.5B | $0.5B | $1.0B | $2.7B | $-0.0B | $-0.7B |